MARR SPA (MARR.MI) Fundamental Analysis & Valuation

BIT:MARR • IT0003428445

Current stock price

7.92 EUR
+0.08 (+1.02%)
Last:

This MARR.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. MARR.MI Profitability Analysis

1.1 Basic Checks

  • MARR had positive earnings in the past year.
  • In the past year MARR had a positive cash flow from operations.
  • In the past 5 years MARR has always been profitable.
  • Of the past 5 years MARR 4 years had a positive operating cash flow.
MARR.MI Yearly Net Income VS EBIT VS OCF VS FCFMARR.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.94%, MARR is in line with its industry, outperforming 44.00% of the companies in the same industry.
  • The Return On Equity of MARR (15.95%) is better than 64.00% of its industry peers.
  • The Return On Invested Capital of MARR (9.21%) is better than 68.00% of its industry peers.
Industry RankSector Rank
ROA 3.94%
ROE 15.95%
ROIC 9.21%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MARR.MI Yearly ROA, ROE, ROICMARR.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20

1.3 Margins

  • The Profit Margin of MARR (1.71%) is worse than 60.00% of its industry peers.
  • In the last couple of years the Profit Margin of MARR has grown nicely.
  • The Operating Margin of MARR (3.04%) is worse than 64.00% of its industry peers.
  • MARR's Operating Margin has improved in the last couple of years.
  • MARR has a worse Gross Margin (8.00%) than 92.00% of its industry peers.
  • In the last couple of years the Gross Margin of MARR has remained more or less at the same level.
Industry RankSector Rank
OM 3.04%
PM (TTM) 1.71%
GM 8%
OM growth 3Y10.28%
OM growth 5Y139.42%
PM growth 3Y1.89%
PM growth 5YN/A
GM growth 3Y-1.71%
GM growth 5Y1.18%
MARR.MI Yearly Profit, Operating, Gross MarginsMARR.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20

5

2. MARR.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MARR is creating some value.
  • There is no outstanding debt for MARR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MARR.MI Yearly Shares OutstandingMARR.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
MARR.MI Yearly Total Debt VS Total AssetsMARR.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • MARR has an Altman-Z score of 3.39. This indicates that MARR is financially healthy and has little risk of bankruptcy at the moment.
  • MARR's Altman-Z score of 3.39 is fine compared to the rest of the industry. MARR outperforms 72.00% of its industry peers.
  • The Debt to FCF ratio of MARR is 19.52, which is on the high side as it means it would take MARR, 19.52 years of fcf income to pay off all of its debts.
  • MARR's Debt to FCF ratio of 19.52 is on the low side compared to the rest of the industry. MARR is outperformed by 76.00% of its industry peers.
  • A Debt/Equity ratio of 1.06 is on the high side and indicates that MARR has dependencies on debt financing.
  • MARR's Debt to Equity ratio of 1.06 is in line compared to the rest of the industry. MARR outperforms 48.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF 19.52
Altman-Z 3.39
ROIC/WACC1.38
WACC6.67%
MARR.MI Yearly LT Debt VS Equity VS FCFMARR.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • MARR has a Current Ratio of 1.47. This is a normal value and indicates that MARR is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of MARR (1.47) is better than 88.00% of its industry peers.
  • A Quick Ratio of 1.07 indicates that MARR should not have too much problems paying its short term obligations.
  • MARR has a Quick ratio of 1.07. This is amongst the best in the industry. MARR outperforms 96.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 1.07
MARR.MI Yearly Current Assets VS Current LiabilitesMARR.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

5

3. MARR.MI Growth Analysis

3.1 Past

  • The earnings per share for MARR have decreased by -5.31% in the last year.
  • The Earnings Per Share has been growing slightly by 6.87% on average over the past years.
  • MARR shows a strong growth in Revenue. In the last year, the Revenue has grown by 33.70%.
  • The Revenue has been growing by 14.60% on average over the past years. This is quite good.
EPS 1Y (TTM)-5.31%
EPS 3Y6.87%
EPS 5YN/A
EPS Q2Q%26.65%
Revenue 1Y (TTM)33.7%
Revenue growth 3Y3.32%
Revenue growth 5Y14.6%
Sales Q2Q%92.94%

3.2 Future

  • The Earnings Per Share is expected to grow by 17.81% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 3.92% on average over the next years.
EPS Next Y21.97%
EPS Next 2Y17.81%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.07%
Revenue Next 2Y3.53%
Revenue Next 3Y3.58%
Revenue Next 5Y3.92%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MARR.MI Yearly Revenue VS EstimatesMARR.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
MARR.MI Yearly EPS VS EstimatesMARR.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

7

4. MARR.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • MARR is valuated reasonably with a Price/Earnings ratio of 8.61.
  • MARR's Price/Earnings ratio is rather cheap when compared to the industry. MARR is cheaper than 96.00% of the companies in the same industry.
  • MARR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.60.
  • MARR is valuated reasonably with a Price/Forward Earnings ratio of 11.11.
  • 84.00% of the companies in the same industry are more expensive than MARR, based on the Price/Forward Earnings ratio.
  • MARR's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.84.
Industry RankSector Rank
PE 8.61
Fwd PE 11.11
MARR.MI Price Earnings VS Forward Price EarningsMARR.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, MARR is valued a bit cheaper than 80.00% of the companies in the same industry.
  • MARR's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 22.06
EV/EBITDA 6.58
MARR.MI Per share dataMARR.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • MARR's earnings are expected to grow with 17.81% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.39
PEG (5Y)N/A
EPS Next 2Y17.81%
EPS Next 3YN/A

6

5. MARR.MI Dividend Analysis

5.1 Amount

  • MARR has a Yearly Dividend Yield of 6.46%, which is a nice return.
  • MARR's Dividend Yield is rather good when compared to the industry average which is at 2.72. MARR pays more dividend than 92.00% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.88, MARR pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.46%

5.2 History

  • The dividend of MARR decreases each year by -5.06%.
Dividend Growth(5Y)-5.06%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 73.12% of the earnings are spent on dividend by MARR. This is not a sustainable payout ratio.
DP73.12%
EPS Next 2Y17.81%
EPS Next 3YN/A
MARR.MI Yearly Income VS Free CF VS DividendMARR.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M 80M 100M
MARR.MI Dividend Payout.MARR.MI Dividend Payout, showing the Payout Ratio.MARR.MI Dividend Payout.PayoutRetained Earnings

MARR.MI Fundamentals: All Metrics, Ratios and Statistics

MARR SPA

BIT:MARR (4/2/2026, 7:00:00 PM)

7.92

+0.08 (+1.02%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)03-17
Earnings (Next)05-15
Inst Owners24.06%
Inst Owner ChangeN/A
Ins Owners50.42%
Ins Owner ChangeN/A
Market Cap526.92M
Revenue(TTM)4.07B
Net Income(TTM)52.62M
Analysts76.67
Price Target10.13 (27.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.46%
Yearly Dividend0.6
Dividend Growth(5Y)-5.06%
DP73.12%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.74%
PT rev (3m)-14.74%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)-0.13%
Valuation
Industry RankSector Rank
PE 8.61
Fwd PE 11.11
P/S 0.17
P/FCF 22.06
P/OCF 9.27
P/B 1.6
P/tB 3.29
EV/EBITDA 6.58
EPS(TTM)0.92
EY11.62%
EPS(NY)0.71
Fwd EY9%
FCF(TTM)0.36
FCFY4.53%
OCF(TTM)0.85
OCFY10.79%
SpS46.22
BVpS4.96
TBVpS2.41
PEG (NY)0.39
PEG (5Y)N/A
Graham Number10.13
Profitability
Industry RankSector Rank
ROA 3.94%
ROE 15.95%
ROCE 13.34%
ROIC 9.21%
ROICexc 13.17%
ROICexgc 20.14%
OM 3.04%
PM (TTM) 1.71%
GM 8%
FCFM 0.78%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y10.28%
OM growth 5Y139.42%
PM growth 3Y1.89%
PM growth 5YN/A
GM growth 3Y-1.71%
GM growth 5Y1.18%
F-Score5
Asset Turnover2.3
Health
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF 19.52
Debt/EBITDA 2.94
Cap/Depr 129.56%
Cap/Sales 1.07%
Interest Coverage 4.6
Cash Conversion 47.79%
Profit Quality 45.39%
Current Ratio 1.47
Quick Ratio 1.07
Altman-Z 3.39
F-Score5
WACC6.67%
ROIC/WACC1.38
Cap/Depr(3y)116.01%
Cap/Depr(5y)95.38%
Cap/Sales(3y)1.3%
Cap/Sales(5y)1.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.31%
EPS 3Y6.87%
EPS 5YN/A
EPS Q2Q%26.65%
EPS Next Y21.97%
EPS Next 2Y17.81%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)33.7%
Revenue growth 3Y3.32%
Revenue growth 5Y14.6%
Sales Q2Q%92.94%
Revenue Next Year3.07%
Revenue Next 2Y3.53%
Revenue Next 3Y3.58%
Revenue Next 5Y3.92%
EBIT growth 1Y-20.86%
EBIT growth 3Y13.94%
EBIT growth 5Y174.37%
EBIT Next Year91.8%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-61.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-35.14%
OCF growth 3YN/A
OCF growth 5Y-9.51%

MARR SPA / MARR.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of MARR SPA (MARR.MI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to MARR.MI.


What is the valuation status for MARR stock?

ChartMill assigns a valuation rating of 7 / 10 to MARR SPA (MARR.MI). This can be considered as Undervalued.


Can you provide the profitability details for MARR SPA?

MARR SPA (MARR.MI) has a profitability rating of 4 / 10.


What is the financial health of MARR SPA (MARR.MI) stock?

The financial health rating of MARR SPA (MARR.MI) is 5 / 10.


How sustainable is the dividend of MARR SPA (MARR.MI) stock?

The dividend rating of MARR SPA (MARR.MI) is 6 / 10 and the dividend payout ratio is 73.12%.